PubMed for Bookshelf ID: 4854352

Year	Number of Results
2005	1
2006	2
2008	1
2009	1
2010	3
2011	1
2012	1
2014	6
2015	1
2016	2
2017	1
2019	1
2021	2
2024	0

1

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.

Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP. Cai T, et al. BMJ. 2021 Jul 14;374:n1537. doi: 10.1136/bmj.n1537. BMJ. 2021. PMID: 34261627 Free PMC article.

2

HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.

Balasubramanian R, Maideen NMP. Balasubramanian R, et al. Curr Drug Metab. 2021;22(5):328-341. doi: 10.2174/1389200222666210114122729. Curr Drug Metab. 2021. PMID: 33459228 Review.

3

Lipid-lowering drugs.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.

4

Hepatotoxicity of statins and other lipid-lowering agents.

Björnsson ES. Björnsson ES. Liver Int. 2017 Feb;37(2):173-178. doi: 10.1111/liv.13308. Epub 2016 Nov 27. Liver Int. 2017. PMID: 27860156 Review.

5

Statin-induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis.

Wang LY, Huang YS, Perng CL, Huang B, Lin HC. Wang LY, et al. Br J Clin Pharmacol. 2016 Sep;82(3):823-30. doi: 10.1111/bcp.13009. Epub 2016 Jun 17. Br J Clin Pharmacol. 2016. PMID: 27197051 Free PMC article.

6

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network. Chalasani N, et al. Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6. Gastroenterology. 2015. PMID: 25754159 Free PMC article.

7

Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.

Perdices EV, Medina-Cáliz I, Hernando S, Ortega A, Martín-Ocaña F, Navarro JM, Peláez G, Castiella A, Hallal H, Romero-Gómez M, González-Jiménez A, Robles-Díaz M, Lucena MI, Andrade RJ. Perdices EV, et al. Rev Esp Enferm Dig. 2014 Apr;106(4):246-54. Rev Esp Enferm Dig. 2014. PMID: 25075655 Free article.

8

A prospective stratified case-cohort study on statins and multiple adverse events in Japan.

Ooba N, Sato T, Wakana A, Orii T, Kitamura M, Kokan A, Kurata H, Shimodozono Y, Matsui K, Yoshida H, Yamaguchi T, Kageyama S, Kubota K. Ooba N, et al. PLoS One. 2014 May 8;9(5):e96919. doi: 10.1371/journal.pone.0096919. eCollection 2014. PLoS One. 2014. PMID: 24810427 Free PMC article.

9

An assessment by the Statin Liver Safety Task Force: 2014 update.

Bays H, Cohen DE, Chalasani N, Harrison SA, The National Lipid Association's Statin Safety Task Force. Bays H, et al. J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S47-57. doi: 10.1016/j.jacl.2014.02.011. J Clin Lipidol. 2014. PMID: 24793441

10

Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL. Russo MW, et al. Hepatology. 2014 Aug;60(2):679-86. doi: 10.1002/hep.27157. Epub 2014 May 13. Hepatology. 2014. PMID: 24700436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year